Yesterday, Tuberculosis Day was celebrated around the world. It is a memorable date associated with the first description of the causative agent of the disease, Koch's bacillus, which was made 141 years ago.
Vaccination against tuberculosis is carried out in various countries, where everyone is exposed to it at a very early age. One of the best known vaccines is BCG, which is given to newborns in the first few days of life. This vaccination, which has been in use for more than a century, provides protection against tuberculosis in early childhood, when the body is most vulnerable.
Tuberculosis is caused by the bacterium Koch's bacillus, which enters the human body, especially in conditions of weakened immunity, such as starvation or stress. The disease can affect various organs including the lungs, eyes, nervous system and musculoskeletal system. Vaccinations play a key role in preventing severe forms of the disease and reducing the risk of infection.
There are various methods for early diagnosis of TB, including the Mantoux test, which is not a vaccination but helps to assess the level of immunity to the disease in children. However, the development of effective vaccines remains a key aspect of TB control.
Russian scientists have created a new vaccine, such as GAMTBVAC, which is now undergoing clinical trials. This vaccine, while not live, is available even to people with HIV, making it an important tool in preventing TB in this vulnerable population.
Despite declining incidence in a number of countries, tuberculosis remains one of the world's deadliest diseases. It is therefore important to continue efforts to develop effective vaccines, early diagnosis and control the spread of the disease to ensure a healthy future for all.
Advanced Science: TB vaccine stops liver tumor growth.